Rebates will have a lessening impact on drug pricing over the next decade, actuaries with the Centers for Medicare and Medicaid Services predict in a report on National Health Expenditure Projections from 2017-2026, released Feb. 14.
"In 2018 and beyond, the share of total prescription drug spending affected by rebates is not expected to increase as rapidly as in the recent past," the report says. "As...